Group V secreted phospholipase A2 is upregulated by IL-4 in human macrophages and mediates phagocytosis via hydrolysis of ethanolamine phospholipids

Journal of Immunology

Volumn 194, Issue 7, 2015, Pages 3327-3339

  Rubio, Julio M ^a,b   Rodríguez, Juan P ^a,c   Gil de Gómez, Luis ^a   Guijas, Carlos ^a,b   Balboa, María A ^a,b   Balsinde, Jesús ^a,b  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSIDAD NACIONAL DEL NORDESTE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ETHANOLAMINE; GAMMA INTERFERON; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHOSPHOLIPASE A2 GROUP V; ZYMOSAN; ISOENZYME; PHOSPHATIDYLETHANOLAMINE;

ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; LIPID HYDROLYSIS; MACROPHAGE; MALE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; YEAST; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HYDROLYSIS; IMMUNOLOGY; LIPID METABOLISM; METABOLISM; NORMAL HUMAN;

GENE EXPRESSION REGULATION; GROUP V PHOSPHOLIPASES A2; HEALTHY VOLUNTEERS; HUMANS; HYDROLYSIS; INTERLEUKIN-4; ISOENZYMES; LIPID METABOLISM; MACROPHAGES; MALE; PHAGOCYTOSIS; PHOSPHATIDYLETHANOLAMINES;

EID: 84925879158     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401026     Document Type: Article

References (86)

1. 2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem. Rev. 111: 6130-6185.
2. 2 and lysophospholipid acyltransferases. Biochim. Biophys. Acta 1791: 1103-1113.
3. Astudillo, A. M., D. Balgoma, M. A. Balboa, and J. Balsinde. 2012. Dynamics of arachidonic acid mobilization by inflammatory cells. Biochim. Biophys. Acta 1821: 249-256.
4. Brash, A. R. 2001. Arachidonic acid as a bioactive molecule. J. Clin. Invest. 107: 1339-1345.
5. Kihara, Y., M. Maceyka, S. Spiegel, and J. Chun. 2014. Lysophospholipid receptor nomenclature review: IUPHAR Review 8. Br. J. Pharmacol. 171: 3575-3594.
6. 2) regulation of arachidonic acid mobilization. FEBS Lett. 531: 2-6.
7. Leslie, C. C. 2004. Regulation of arachidonic acid availability for eicosanoid production. Biochem. Cell Biol. 82: 1-17.
8. Gordon, S. 2002. Pattern recognition receptors: doubling up for the innate immune response. Cell 111: 927-930.
9. Taylor, P. R., S. V. Tsoni, J. A. Willment, K. M. Dennehy, M. Rosas, H. Findon, K. Haynes, C. Steele, M. Botto, S. Gordon, and G. D. Brown. 2007. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 8: 31-38.
10. Elsori, D. H., V. P. Yakubenko, T. Roome, P. S. Thiagarajan, A. Bhattacharjee, S. P. Yadav, and M. K. Cathcart. 2011. Protein kinase Cδ is a critical component of Dectin-1 signaling in primary human monocytes. J. Leukoc. Biol. 90: 599-611.
11. Underhill, D. M. 2003. Macrophage recognition of zymosan particles. J. Endotoxin Res. 9: 176-180.
12. Vega, M. A., and A. L. Corbí. 2006. Human macrophage activation: too many functions and phenotypes for a single cell type. Inmunologiá 25: 248-272.
13. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
14. Gordon, S., and F. O. Martínez. 2010. Alternative activation of macrophages: mechanism and functions. Immunity 32: 593-604.
15. Sica, A., and A. Mantovani. 2012. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122: 787-795.
16. Wu, D., A. B. Molofsky, H. E. Liang, R. R. Ricardo-Gonzalez, H. A. Jouihan, J. K. Bando, A. Chawla, and R. M. Locksley. 2011. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332: 243-247.
17. Nguyen, K. D., Y. Qiu, X. Cui, Y. P. Goh, J. Mwangi, T. David, L. Mukundan, F. Brombacher, R. M. Locksley, and A. Chawla. 2011. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480: 104-108.
18. Derecki, N. C., A. N. Cardani, C. H. Yang, K. M. Quinnies, A. Crihfield, K. R. Lynch, and J. Kipnis. 2010. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J. Exp. Med. 207: 1067-1080.
19. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3: 23-35.
20. Martinez, F. O., L. Helming, and S. Gordon. 2009. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27: 451-483.
21. 2-derived lysophosphatidylcholine mediates cyclooxygenase-2 induction in lipopolysaccharide-stimulated macrophages. J. Immunol. 179: 631-638.
22. Pindado, J., J. Balsinde, and M. A. Balboa. 2007. TLR3-dependent induction of nitric oxide synthase in RAW 264.7 macrophage-like cells via a cytosolic phospholipase A2/cyclooxygenase-2 pathway. J. Immunol. 179: 4821-4828.
23. 2s. J. Immunol. 182: 3877-3883.
24. Balgoma, D., A. M. Astudillo, G. Pérez-Chacón, O. Montero, M. A. Balboa, and J. Balsinde. 2010. Markers of monocyte activation revealed by lipidomic profiling of arachidonic acid-containing phospholipids. J. Immunol. 184: 3857-3865.
25. Pérez-Chacón, G., A. M. Astudillo, V. Ruipérez, M. A. Balboa, and J. Balsinde. 2010. Signaling role for lysophosphatidylcholine acyltransferase 3 in receptor-regulated arachidonic acid reacylation reactions in human monocytes. J. Immunol. 184: 1071-1078.
26. Valdearcos, M., E. Esquinas, C. Meana, L. Gil-de-Gómez, C. Guijas, J. Balsinde, and M. A. Balboa. 2011. Subcellular localization and role of lipin-1 in human macrophages. J. Immunol. 186: 6004-6013.
27. Astudillo, A. M., G. Pérez-Chacón, C. Meana, D. Balgoma, A. Pol, M. A. Del Pozo, M. A. Balboa, and J. Balsinde. 2011. Altered arachidonate distribution in macrophages from caveolin-1 null mice leading to reduced eicosanoid synthesis. J. Biol. Chem. 286: 35299-35307.
28. Guijas, C., A. M. Astudillo, L. Gil-de-Gómez, J. M. Rubio, M. A. Balboa, and J. Balsinde. 2012. Phospholipid sources for adrenic acid mobilization in RAW 264.7 macrophages. Comparison with arachidonic acid. Biochim. Biophys. Acta 1821: 1386-1393.
29. Gil-de-Gómez, L., A. M. Astudillo, C. Meana, J. M. Rubio, C. Guijas, M. A. Balboa, and J. Balsinde. 2013. A phosphatidylinositol species acutely generated by activated macrophages regulates innate immune responses. J. Immunol. 190: 5169-5177.
30. 2s act on distinct phospholipid pools in zymosan-stimulated mouse peritoneal macrophages. J. Immunol. 192: 752-762.
31. 1 macrophage-like cells. J. Biol. Chem. 278: 48059-48065.
32. 1 macrophages using GFP/RFP constructs. Biochim. Biophys. Acta 1735: 119-129.
33. 2 to phagosomes in human macrophages. J. Immunol. 183: 2767-2774.
34. 2 (Lys488/Lys541/Lys543/Lys544) is involved in translocation of the enzyme to phagosomes in human macrophages. J. Lipid Res. 51: 388-399.
35. 2-dependent synthesis of lipid droplets in human monocytes. J. Lipid Res. 53: 2343-2354.
36. Valdearcos, M., E. Esquinas, C. Meana, L. Peña, L. Gil-de-Gómez, J. Balsinde, and M. A. Balboa. 2012. Lipin-2 reduces proinflammatory signaling induced by saturated fatty acids in macrophages. J. Biol. Chem. 287: 10894-10904.
37. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25: 677-686.
38. Martínez, F. O., and S. Gordon. 2014. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6: 13.
39. Martínez, F. O., L. Helming, R. Milde, A. Varin, B. N. Melgert, C. Draijer, B. Thomas, M. Fabbri, A. Crawshaw, L. P. Ho, et al. 2013. Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. Blood 121: e57-e69.
40. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
41. Diez, E., J. Balsinde, M. Aracil, and A. Schüller. 1987. Ethanol induces release of arachidonic acid but not synthesis of eicosanoids in mouse peritoneal macrophages. Biochim. Biophys. Acta 921: 82-89.
42. Winkler, J. D., C. M. Sung, C. F. Bennett, and F. H. Chilton. 1991. Characterization of CoA-independent transacylase activity in U937 cells. Biochim. Biophys. Acta 1081: 339-346.
43. 2 in providing lysophospholipid acceptors for fatty acid phospholipid incorporation and remodelling. Biochem. J. 364: 695-702.
44. 2 in hydrogen peroxide-induced accumulation of free fatty acids in human U937 cells. J. Biol. Chem. 277: 40384-40389.
45. 2 in arachidonic acid release, phospholipid fatty acid incorporation, and apoptosis in U937 cells responding to hydrogen peroxide. J. Biol. Chem. 279: 40385-40391.
46. 2 in macrophage engulfment of hydrogen peroxide-treated U937 cells. J. Immunol. 176: 2555-2561.
47. 2 mediates proliferation of human promonocytic U937 cells. FEBS J. 275: 1915-1924.
48. Brouwer, N., K. M. Dolman, M. van Houdt, M. Sta, D. Roos, and T. W. Kuijpers. 2008. Mannose-binding lectin (MBL) facilitates opsonophagocytosis of yeasts but not of bacteria despite MBL binding. J. Immunol. 180: 4124-4132.
49. 2 translocates to forming phagosomes during phagocytosis of zymosan in macrophages. J. Biol. Chem. 279: 19113-19121.
50. 2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis. J. Biol. Chem. 281: 6691-6698.
51. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
52. 2-mediated formation of 1,2-diarachidonoyl-glycerophosphoinositol in monocytes. FEBS J. 275: 6180-6191.
53. Astudillo, A. M., G. Pérez-Chacón, D. Balgoma, L. Gil-de-Gómez, V. Ruipérez, C. Guijas, M. A. Balboa, and J. Balsinde. 2011. Influence of cellular arachidonic acid levels on phospholipid remodeling and CoA-independent transacylase activity in human monocytes and U937 cells. Biochim. Biophys. Acta 1811: 97-103.
54. Dumlao, D. S., M. W. Buczynski, P. C. Norris, R. Harkewicz, and E. A. Dennis. 2011. High-throughput lipidomic analysis of fatty acid derived eicosanoids and N-acylethanolamines. Biochim. Biophys. Acta 1811: 724-736.
55. 2s. J. Biol. Chem. 274: 12263-12268.
56. 2)-dependent induction of cyclooxygenase-2 in macrophages. J. Biol. Chem. 274: 25967-25970.
57. 1) macrophages. J. Biol. Chem. 275: 4783-4786.
58. 1 macrophage-like cells. J. Biol. Chem. 275: 22544-22549.
59. 2 expression and function by proinflammatory stimuli. Eur. J. Biochem. 263: 826-835.
60. 2: classical and novel functions. Biochim. Biophys. Acta 1761: 1280-1288.
61. 2). Biochim. Biophys. Acta 1488: 48-58.
62. 2 enzymes: Lessons from transgenic and knockout mice. Biochimie 92: 561-582.
63. Fahy, E., S. Subramaniam, H. A. Brown, C. K. Glass, A. H. Merrill, Jr., R. C. Murphy, C. R. Raetz, D. W. Russell, Y. Seyama, W. Shaw, et al. 2005. A comprehensive classification system for lipids. J. Lipid Res. 46: 839-861.
64. Stafford, R. E., T. Fanni, and E. A. Dennis. 1989. Interfacial properties and critical micelle concentration of lysophospholipids. Biochemistry 28: 5113-5120.
65. Grzelczyk, A., and E. Gendaszewska-Darmach. 2013. Novel bioactive glycerol-based lysophospholipids: new data - new insight into their function. Biochimie 95: 667-679.
66. 2 in zymosan-induced eicosanoid generation and vascular permeability revealed by targeted gene disruption. J. Biol. Chem. 279: 16488-16494.
67. 2 generation in mouse bone marrow culture-derived mast cells in a strain-dependent manner. Biochim. Biophys. Acta 1761: 1489-1497.
68. 2α activation. Blood 110: 561-567.
69. 2 modulates phagosome maturation and regulates the innate immune response against Candida albicans. J. Immunol. 182: 4891-4898.
70. Degousee, N., F. Ghomashchi, E. Stefanski, A. Singer, B. P. Smart, N. Borregaard, R. Reithmeier, T. F. Lindsay, C. Lichtenberger, W. Reinisch, et al. 2002. Groups IV, V, and X phospholipases A2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis. J. Biol. Chem. 277: 5061-5073.
71. 2 internalization and degradation. J. Biol. Chem. 276: 11126-11134.
72. 2-independent cysteinyl leukotriene synthesis in human eosinophils. J. Biol. Chem. 278: 38813-38820.
73. 2 in immune complex-mediated arthritis. EMBO Mol. Med. 2: 172-187.
74. 2 is involved in macrophage activation and is sufficient for macrophage effector functions in allergic pulmonary inflammation. J. Immunol. 190: 5927-5938.
75. Frasch, S. C., K. Zemski-Berry, R. C. Murphy, N. Borregaard, P. M. Henson, and D. L. Bratton. 2007. Lysophospholipids of different classes mobilize neutrophil secretory vesicles and induce redundant signaling through G2A. J. Immunol. 178: 6540-6548.
76. Simons, K., and J. L. Sampaio. 2011. Membrane organization and lipid rafts. Cold Spring Harb. Perspect. Biol. 3: a004697.
77. García-García, E., E. J. Brown, and C. Rosales. 2007. Transmembrane mutations to FcgammaRIIA alter its association with lipid rafts: implications for receptor signaling. J. Immunol. 178: 3048-3058.
78. Beekman, J. M., J. A. van der Linden, J. G. van de Winkel, and J. H. Leusen. 2008. FcgammaRI (CD64) resides constitutively in lipid rafts. Immunol. Lett. 116: 149-155.
79. Bournazos, S., S. P. Hart, L. H. Chamberlain, M. J. Glennie, and I. Dransfield. 2009. Association of FcgammaRIIa (CD32a) with lipid rafts regulates ligand binding activity. J. Immunol. 182: 8026-8036.
80. Pike, L. J., X. Han, K.-N. Chung, and R. Gross. 2002. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry 41: 2075-2088.
81. Gorgas, K., A. Teigler, D. Komljenovic, and W. W. Just. 2006. The ether lipid-deficient mouse: tracking down plasmalogen functions. Biochim. Biophys. Acta 1763: 1511-1526.
82. 2IVα regulates phagocytosis independent of its enzymatic activity. J. Biol. Chem. 287: 16849-16859.
83. Peters-Golden, M., C. Canetti, P. Mancuso, and M. J. Coffey. 2005. Leukotrienes: underappreciated mediators of innate immune responses. J. Immunol. 174: 589-594.
84. 2 regulation of lipid droplet formation. Biochim. Biophys. Acta 1841: 1661-1671.
85. 2 antagonist, and the acyl coenzyme A: cholesterol acyltransferase inhibitor programs. Curr. Opin. Lipidol. 24: 459-466.
86. Nicholls, S. J., J. J. Kastelein, G. G. Schwartz, D. Bash, R. S. Rosenson, M. A. Cavender, D. M. Brennan, W. Koenig, J. W. Jukema, V. Nambi, et al; VISTA-16 Investigators. 2014. Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. JAMA 311: 252-262.